title: Reply by the authors.
authors: Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, MD.
authors: Jonathan
authors: J
authors: Jarow
authors: Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, MD.
authors: Paul G
authors: PG
authors: Kluetz
authors: Scott Department of Urology, Baylor College of Medicine Medical Center, Houston, TX.
authors: Seth P
authors: SP
authors: Lerner
authors: Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
authors: Ke
authors: K
authors: Liu
authors: Division of Biometrics V, Office of Biostatistics, CDER, Food and Drug Administration, Silver Spring, MD.
authors: Rajeshwari
authors: R
authors: Sridhara
authors: Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
authors: Dean
authors: D
authors: Bajorin
authors: Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN.
authors: Sam
authors: S
authors: Chang
authors: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors: Colin P N
authors: CP
authors: Dinney
authors: Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, USC/Keck School of Medicine, Los Angeles, CA.
authors: Susan
authors: S
authors: Groshen
authors: American Medical Systems, Minnetonka, MN.
authors: Ronald A
authors: RA
authors: Morton
authors: University of Iowa, Iowa city, IA.
authors: Michael
authors: M
authors: O'Donnell
authors: Bladder Cancer Advocacy Network, Bethesda, MD.
authors: Diane Zipursky
authors: DZ
authors: Quale
authors: The Johns Hopkins University School of Medicine, Baltimore, MD.
authors: Mark
authors: M
authors: Schoenberg
authors: Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH.
authors: John
authors: J
authors: Seigne
authors: National Cancer Institute, Bethesda, MD.
authors: Bhadrasain
authors: B
authors: Vikram
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000628:therapy*